Showing 1-10 of 340 results for "".

• Treatment of Focal Epilepsy with Cenobamate Associated with Lower Inpatient Days and ER Visits Compared with 7 Leading Anti-Seizure Medications
  https://practicalneurology.com/news/treatment-of-focal-epilepsy-with-cenobamate-associated-with-lower-inpatient-days-and-er-visits-compared-with-7-leading-anti-seizure-medications/2470448/
  The addition of cenobamate to the treatment regimens of people with focal epilepsy was associated with lower rates of inpatient days and emergency room (ER) visits compared with the addition of 7 other leading anti-seizure medications (ASMs). This finding, which was presented at the American Acad
• Physician Visits Increased Up to 15 Years Before MS Symptom Onset
  https://practicalneurology.com/news/physician-visits-increased-up-to-15-years-before-ms-symptom-onset/2476101/
  Results from a large, matched cohort study published in JAMA Network Open reveal that health care use begins to rise 14 to 15 years before the onset of the first recognized symptoms of multiple sclerosis (MS). The findings suggest a longer prodromal phase than previously understood, with
• Prescription Digital Therapeutic Reduced Insomnia Severity and Decreased Emergency Department Visits 
  https://practicalneurology.com/news/prescription-digital-therapeutic-reduced-insomnia-severity-and-decreased-emergency-department-visits/2470000/
  In analysis of real-world data, prescription digital therapeutic (PDT) (Somryst; Pear Therapeutics, Boston, MA) showed clinically meaningful reductions in insomnia severity index (ISI) score after 9 weeks of. People who used the PDT also had reductions in health-related services and costs in the
• Study Suggests Key Topics to Discuss in Initial Alzheimer’s Diagnostic Visit
  https://practicalneurology.com/news/study-suggests-key-topics-to-discuss-in-initial-alzheimers-diagnostic-visit/2468963/
  Research has identified 17 topics in 4 categories that people with Alzheimer’s disease (AD), their caregivers, and health care professionals feel are important to discuss, as well as the timing for the discussion topics (Table). 
• Evidence Shows Telemedicine With Neurologists Is Effective For Patients and Caregivers
  https://practicalneurology.com/news/evidence-shows-telemedicine-with-neurologists-is-effective-for-patients-and-caregivers/2469091/
  According to a review of the evidence conducted by the American Academy of Neurology (AAN) and published in the journal Neurology, seeing a neurologist by video may be as effective as an in-person visit.
• Clinical Trial of Nanocrystalline Gold for Amyotrophic Lateral Sclerosis Completes Double-Blinded Phase
  https://practicalneurology.com/news/clinical-trial-of-nanocrystalline-gold-for-amyotrophic-lateral-sclerosis-completes-double-blinded-phase/2469688/
  All patient visits have been completed in the phase 2 study (NCT04098406) of catalytically active gold nanocrystals (Clene Nanomedicine, Salt Lake City, UT) for early-stage amyotrophic lateral scl
• Gabapentin Users Experienced Fewer Falls than Duloxetine Users
  https://practicalneurology.com/news/gabapentin-users-experienced-fewer-falls-than-duloxetine-users/2470943/
  Treatment with gabapentin may be associated with a reduced risk of falls compared with duloxetine, according to study results published in the Annals of Internal Medicine. Gabapentin users demonstrated significantly fewer fall-related healthcare visits compared with duloxetine users and an approx
• Individuals With Poorly Controlled Type 1 Diabetes May Have More Risk of Dementia
  https://practicalneurology.com/news/individuals-with-poorly-controlled-type-1-diabetes-may-have-more-risk-of-dementia/2469604/
  According to research published in Neurology, individuals with type 1 diabetes who have been to the hospital at some point for hypo- or hyperglycemia may be at 6 times more risk for developing dementia years later. The study found individuals with type 1 diabetes who visited the hospital
• Opioid Use for Migraine Treatment Remains High, Especially in Emergency Department
  https://practicalneurology.com/news/opioid-use-for-migraine-treatment-remains-high-especially-when-treatment-occurs-in-the-emergency-department/2468955/
  A retrospective analysis of electronic health records from 2010 through 2016 evaluated 14,494 emergency department visits for migraine. In 23%, opioids were given within 12 hours of presentation. When opioids were given, they were the first therapy given more than half the time (58%). Likelihood
• Last Patient Fully Assessed in Trial of Accordion Formulation of Levodopa/Carbidopa for Parkinson's Disease
  https://practicalneurology.com/news/last-patient-fully-assessed-in-trial-of-accordion-formulation-of-levodopacarbidopa-for-parkinsons-disease/2468878/
  The final patient completed their last physician visit in a pivotal phase 3 clinical trial for the accordion pill formulation of carbidopa/levodopa (AP-CD/LD) (Intec Pharma, Jerusalem, Israel) for treating advanced Parkinson’s disease (PD).  A gastric-retentive drug delivery sy

• Prev
• 1
• 2
• 3
• …
• 33
• 34
• Next